Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety
Vox Sang
.
2021 Jan;116(1):13-14.
doi: 10.1111/vox.12964.
Epub 2020 Jun 24.
Authors
Jay Epstein
1
,
W Martin Smid
2
,
Silvano Wendel
3
,
Daniel Somuah
4
,
Thierry Burnouf
5
Affiliations
1
US Food and Drug Administration, Silver Spring, MD, USA.
2
Sanquin Consulting Services, Amsterdam, Academic Institute IDTM, Groningen, The Netherlands.
3
Blood Bank, Hospital Sirio Libanês, São Paulo, Brasil.
4
Anglogold Ashanti Health Foundation Hospital, Obuasi, Ghana.
5
Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
PMID:
32464700
PMCID:
PMC7283681
DOI:
10.1111/vox.12964
No abstract available